Cannabinoids and Dementia: A Review of Clinical and Preclinical Data

The endocannabinoid system has been shown to be associated with neurodegenerative diseases and dementia. We review the preclinical and clinical data on cannabinoids and four neurodegenerative diseases: Alzheimer’s disease (AD), Huntington’s disease (HD), Parkinson’s disease (PD) and vascular dementi...

Descripción completa

Detalles Bibliográficos
Autores principales: Walther, Sebastian, Halpern, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033945/
https://www.ncbi.nlm.nih.gov/pubmed/27713372
http://dx.doi.org/10.3390/ph3082689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033945/
https://www.ncbi.nlm.nih.gov/pubmed/27713372
http://dx.doi.org/10.3390/ph3082689

Ejemplares similares